Sheren Younes

1.6k total citations
19 papers, 176 citations indexed

About

Sheren Younes is a scholar working on Pathology and Forensic Medicine, Oncology and Epidemiology. According to data from OpenAlex, Sheren Younes has authored 19 papers receiving a total of 176 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 9 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Sheren Younes's work include Lymphoma Diagnosis and Treatment (6 papers), CAR-T cell therapy research (4 papers) and Viral-associated cancers and disorders (4 papers). Sheren Younes is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), CAR-T cell therapy research (4 papers) and Viral-associated cancers and disorders (4 papers). Sheren Younes collaborates with scholars based in United States, Egypt and Saudi Arabia. Sheren Younes's co-authors include Yasodha Natkunam, Roger A. Warnke, Izidore S. Lossos, Jason Karamchandani, Andrew H. Beck, Ronald Levy, Amal F. Dawood, Robert S. Ohgami, Shuchun Zhao and Lauren E. Abrey and has published in prestigious journals such as The American Journal of Surgical Pathology, British Journal of Haematology and Human Pathology.

In The Last Decade

Sheren Younes

17 papers receiving 174 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheren Younes United States 8 83 54 44 39 37 19 176
Chad P. Soupir United States 8 52 0.6× 42 0.8× 92 2.1× 25 0.6× 22 0.6× 9 304
Nicolas Weinbreck France 12 46 0.6× 72 1.3× 28 0.6× 66 1.7× 54 1.5× 21 280
Bérengère Gruson France 10 76 0.9× 51 0.9× 101 2.3× 15 0.4× 39 1.1× 21 328
Renee H. Grau United States 5 55 0.7× 29 0.5× 27 0.6× 150 3.8× 30 0.8× 7 258
Réda Garidi France 9 101 1.2× 63 1.2× 93 2.1× 15 0.4× 18 0.5× 16 261
Dimas Suárez‐Vilela Spain 6 41 0.5× 49 0.9× 41 0.9× 12 0.3× 50 1.4× 8 174
Kseniya Petrova‐Drus United States 7 80 1.0× 54 1.0× 43 1.0× 24 0.6× 9 0.2× 20 183
Kiyomi Mashima Japan 10 46 0.6× 45 0.8× 44 1.0× 21 0.5× 8 0.2× 29 206
Julie Crawford Australia 6 87 1.0× 170 3.1× 63 1.4× 44 1.1× 10 0.3× 11 263
Meenakshi Swain India 9 93 1.1× 53 1.0× 27 0.6× 8 0.2× 80 2.2× 37 262

Countries citing papers authored by Sheren Younes

Since Specialization
Citations

This map shows the geographic impact of Sheren Younes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheren Younes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheren Younes more than expected).

Fields of papers citing papers by Sheren Younes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheren Younes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheren Younes. The network helps show where Sheren Younes may publish in the future.

Co-authorship network of co-authors of Sheren Younes

This figure shows the co-authorship network connecting the top 25 collaborators of Sheren Younes. A scholar is included among the top collaborators of Sheren Younes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheren Younes. Sheren Younes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bulterys, Philip L., Sebastian Fernandez‐Pol, Sheren Younes, et al.. (2025). Expression of CD47 protein in hematolymphoid neoplasms: Implications for CD47-mediated cancer immunotherapy. American Journal of Clinical Pathology. 163(6). 883–897.
2.
3.
Younes, Sheren, Carlos J. Suarez, Jennifer Pogoriler, et al.. (2024). Congenital Peribronchial Myofibroblastic Tumors Harbor a Recurrent EGFR Kinase Domain Duplication. Modern Pathology. 38(2). 100661–100661. 3 indexed citations
4.
Saleem, Atif, et al.. (2024). Epstein-Barr virus latency patterns in polymorphic lymphoproliferative disorders and lymphomas in immunodeficiency settings: Diagnostic implications. Annals of Diagnostic Pathology. 70. 152286–152286. 7 indexed citations
5.
Younes, Sheren, Shuchun Zhao, Robbie G. Majzner, et al.. (2023). Detection of Aberrant CD58 Expression in a Wide Spectrum of Lymphoma Subtypes: Implications for Treatment Resistance. Modern Pathology. 36(10). 100256–100256. 10 indexed citations
6.
Zhao, Shuchun, et al.. (2023). TIGIT is Frequently Expressed in the Tumor Microenvironment of Select Lymphomas. The American Journal of Surgical Pathology. 48(3). 337–352. 3 indexed citations
7.
Fei, Fei, et al.. (2022). EBV-positive nodular lymphocyte predominant Hodgkin lymphoma: a single institution experience. Human Pathology. 129. 32–39. 2 indexed citations
8.
Younes, Sheren, et al.. (2022). Strong Coexpression of Transcription Factors PU.1 and Oct-2 in Rosai-Dorfman Disease. American Journal of Clinical Pathology. 158(6). 672–677. 7 indexed citations
9.
10.
11.
Dawood, Amal F., et al.. (2019). Cross-talk between apelin and vasopressin in response to different osmotic stimuli in type 2 diabetic rats.. PubMed. 32(5). 1117–1127. 4 indexed citations
12.
Dawood, Amal F., et al.. (2019). Relation between resistin, PPAR-γ, obesity and atherosclerosis in male albino rats. Archives of Physiology and Biochemistry. 126(5). 389–398. 8 indexed citations
13.
Abdou, Asmaa Gaber, et al.. (2015). The Diagnostic Impact of C4d, CD68, and NF-κB Expression in the Differentiation Between Recurrent Hepatitis C and Acute Cellular Rejection After Liver Transplantation. Applied immunohistochemistry & molecular morphology. 24(9). 639–647. 4 indexed citations
14.
Bayraktar, Soley, Elizabeth P. Weinzierl, Sheren Younes, et al.. (2014). LMO2 andBCL6 are associated with improved survival in primary central nervous system lymphoma. British Journal of Haematology. 165(5). 640–648. 23 indexed citations
15.
Younes, Sheren, et al.. (2013). FHIT, EGFR, and MSH2. Applied immunohistochemistry & molecular morphology. 22(4). 275–283. 4 indexed citations
16.
Karamchandani, Jason, Sheren Younes, Roger A. Warnke, & Yasodha Natkunam. (2012). IgG4-Related Systemic Sclerosing Disease of the Ocular Adnexa. American Journal of Clinical Pathology. 137(5). 699–711. 36 indexed citations
17.
Younes, Sheren, Andrew H. Beck, Robert S. Ohgami, et al.. (2011). The Efficacy of HGAL and LMO2 in the Separation of Lymphomas Derived From Small B Cells in Nodal and Extranodal Sites, Including the Bone Marrow. American Journal of Clinical Pathology. 135(5). 697–708. 19 indexed citations
18.
Younes, Sheren, Andrew H. Beck, Izidore S. Lossos, et al.. (2010). Immunoarchitectural Patterns in Follicular Lymphoma: Efficacy of HGAL and LMO2 in the Detection of the Interfollicular and Diffuse Components. The American Journal of Surgical Pathology. 34(9). 1266–1276. 31 indexed citations
19.
Younes, Sheren, Bernadett Pályi, István Vályi‐Nagy, et al.. (2007). Endotoxins do not influence transplacental transmission of lymphotropic human herpesviruses and human papillomaviruses into amniotic fluid taken from healthy mothers before parturition in Hungary. Acta Microbiologica et Immunologica Hungarica. 54(3). 279–303. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chad P. Soupir Breakdown of academic impact, for papers by Nicolas Weinbreck Breakdown of academic impact, for papers by Bérengère Gruson Breakdown of academic impact, for papers by Renee H. Grau Breakdown of academic impact, for papers by Réda Garidi Breakdown of academic impact, for papers by Dimas Suárez‐Vilela Breakdown of academic impact, for papers by Kseniya Petrova‐Drus Breakdown of academic impact, for papers by Kiyomi Mashima Breakdown of academic impact, for papers by Julie Crawford Breakdown of academic impact, for papers by Meenakshi Swain
Rankless by CCL
2026